Corbus Pharmaceuticals Holdings, Inc.
CRBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595097
In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 99 | 1 | 86 | −12 |
| Shares | 11.0M | 28.9K | 10.4M | −492.8K (−4.5%) |
| Value | $129.3M | $341.5K | $55.4M | −$73.5M (−57.0%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Exome Asset Management LLC | 289,690 | $1.54M | 1.38% |
| Acadian Asset Management LLC | 190,093 | $1.01M | 0.00% |
| AQR Capital Management LLC | 107,983 | $573.4K | 0.00% |
| Citadel Advisors LLC | 92,991 | $493.8K | 0.00% |
| Prelude Capital Management, LLC | 80,347 | $426.6K | 0.04% |
| Quest Partners LLC | 56,390 | $299.4K | 0.03% |
| Nuveen, LLC | 45,689 | $242.6K | 0.00% |
| Stonepine Capital Management, LLC | 35,000 | $185.8K | 0.22% |
| Verition Fund Management LLC | 22,485 | $119.4K | 0.00% |
| SEI Investments Co | 17,589 | $93.4K | 0.00% |
| Occudo Quantitative Strategies LP | 13,073 | $72.2K | 0.01% |
| Mariner, LLC | 12,290 | $65.3K | 0.00% |
| Massmutual Trust Co FSB | 148 | $786 | 0.00% |
| ORG Partners LLC | 100 | $503 | 0.00% |
| Federated Hermes, Inc. | 64 | $340 | 0.00% |
| Eastern Bank | 6 | $32 | 0.00% |
| Northwestern Mutual Wealth Management Co | 2 | $11 | 0.00% |
Sold out (29)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (1)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 28,938 | $341.5K |